Screening for diabetes with just a photo of the eye

AI-powered detection of pre-diabetes and diabetes for clinicians. Fast, affordable, and accessible on any device.

Regulatory Information

115.2 M

Americans have prediabetes

8 in 10

Adults with prediabetes don’t know they have it

2.6x

The healthcare costs of non-diabetics

Our Solution: VeraScan

We provide the world’s first AI model to detect prediabetes and diabetes from a simple image of the eye. At a fraction of the cost, it can work on any device and provides results in under 5 minutes.

01

Capture

Retinal scan on any device, including a smartphone in just seconds

02

Analyze

Proprietary AI detects retinal biomarkers linked to the diseases

03

Detect

Classifies risk levels for associated diseases with minutes

04

Report

Provides an annotated, clinician-ready report directly on the platform

AI-Driven Diabetes Detection. Anytime. Anywhere.

Non-invasive & device-agnostic

Works with any device, including smartphones, and no dilation is required

Affordable

A fraction of lab-based screening costs

Faster

AI Analysis and reporting in under 5 minutes

Scalable

Built for preventative, mass-screening programs

Technology That Everyone Can Trust

For Patients

We believe every patient deserves the best possible care. Our program is precise, quick, and easy to access, offering patients quality healthcare.

For Providers

We're dedicated to helping providers deliver optimal clinical outcomes. With our easy-to-integrate program, organizations can effectively screen patients.

For Payors

Our adaptive AI continuously improves through pilot feedback, detecting early microvascular biomarkers that others can’t.

A Product Backed by Precise Data

Trained on ~500k retinal scans and growing, VeraScan is founded on rigorous research methodologies.

An Architecture Built for Success

By detecting diabetes at its early stages, we help prevent expensive complications and reduce the burden on patients and insurance providers.

A Future With More Applications

Our platform is scalable, which means expansion into other detectable diseases integrated into a single platform.

OUR MISSION

We aim to improve the early detection and management of chronic diseases.

Improving patient outcomes

VeraScan reduces the effort and cost burden on today’s healthcare system.

Expanding into other diseases

We look towards neurological and metabolic diseases that can also be diagnosed through retinal biomarkers.

Building world-class software and hardware

We transform how health data is collected and analyzed for more informed decisions and treatment plans

Meet the Team

Vedika Kanchan

GROWTH & PRODUCT

A Stanford graduate with growth-experience from Prairie Health (acquired by Carbon Health), Virufy, and Amelia (acquired by XR Health). Her research contributions include Stanford’s COVID-19 Innovation Lab, the SPARQ Think Tank, NextDoor, and Stanford Medical School.

LINKEDIN
Bhavin Mehta

TECHNOLOGY

A seasoned digital and AI transformation specialist with 25 years of executive experience at Accenture. He has shown expertise in technology strategy, enterprise architecture, and large-scale complex implementation programs. His leadership spans various Fortune 500 clients.

LINKEDIN
Manoj Gursahani

RESEARCH & COMPLIANCE

A founder of India’s first e-commerce platform and a proactive leader in rural healthcare reform and philanthropy. Serves on hospital boards and the ethics committee of Lion Tarachand Bapa Hospital, a national medical research center, and renowned Somaiya Hospital.

LINKEDIN